References
Serotonin toxicity: pre-hospital recognition and management
Abstract
Serotonin toxicity is a preventable, potentially serious condition caused by an increase in the neurotransmitter serotonin. The condition can produce a wide variety of symptoms ranging from mild to life threatening. Common signs of severe life threatening toxicity include clonus, myoclonus, hyperreflexia, muscle rigidity and hyperthermia. Serotonin toxicity is caused by taking one or more serotonergic agents which are responsible for raising intrasynaptic serotonin to an abnormally high level. Severe and fatal toxicity are usually associated with taking two different serotonergic agents with different pharmacological actions such as selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). There is no specific pre-hospital treatment for serotonin toxicity. It is based mainly on patients presenting signs and symptoms. The cessation of any serotonergic agents will normally resolve symptoms within 24 hours. Unfortunately it is a condition still not widely recognised by health care professionals (HCP), therefore it is important pre-hospital clinicians are aware of the clinical features of the condition and how best to manage them.
Serotonin toxicity is an increasingly common and potentially life threatening medical condition caused by an excess of the neurotransmitter serotonin. The condition can occur as a consequence of a drug overdose, drug interaction or as the result of an adverse drug reaction (Boyer and Shannon, 2005).
Serotonin toxicity is characterised by a triad of neuroexcitatory signs—namely, mental status changes, autonomic hyperactivity and neuromuscular abnormalities. This triad occurs due to an increased level of intrasynaptic serotonin which in turn causes excessive stimulation of serotonin receptors (Dunkley et al, 2003).
Statistics on serotonin toxicity cases within the UK are sparse but Bronstein et al (2010) found, on analysis of poison centre data from the USA, that there were 48 204 exposures to selective serotonin re-uptake inhibitors (SSRIs) (one of the most common medications associated with serotonin toxicity) in which 1 382 patients developed serious symptoms and 97 died.
Subscribe to get full access to the Journal of Paramedic Practice
Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.
What's included
-
CPD Focus
-
Develop your career
-
Stay informed